Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Daly

Showing results (61-70 of 92) with videos related to

Pageof 10
Sort By:
Plos One|December 16, 2024
The challenge of preventing extinctions: Lessons from managing threatened land snails on Norfolk IslandIsabel T Hyman, Monique Van Sluys, Junn Kitt Foon, et al.
Current Oncology (Toronto, Ont.)|December 22, 2022
Abstracts of the Cell Therapy Transplant Canada 2022 Annual ConferenceStephanie A Maier, Tobias Berg, Susan Berrigan, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 24, 2018
Choosing Wisely BMT: American Society for Blood and Marrow Transplantation and Canadian Blood and Marrow Transplant Group's List of 5 Tests and Treatments to Question in Blood and Marrow TransplantationSita Bhella, Navneet S Majhail, Jeffrey Betcher, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 11, 2014
Immune cell subset counts associated with graft-versus-host diseasePeter J Podgorny, Yiping Liu, Poonam Dharmani-Khan, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 23, 2013
Establishing a target exposure for once-daily intravenous busulfan given with fludarabine and thymoglobulin before allogeneic transplantationJames A Russell, Shahbal B Kangarloo, Tyler Williamson, et al.
Bone Marrow Transplantation|November 8, 2023
Upfront allogeneic transplantation versus JAK inhibitor therapy for patients with myelofibrosis: a North American collaborative studyDawn Maze, Murat O Arcasoy, Ryan Henrie, et al.
Bone Marrow Transplantation|January 26, 2024
Correction: Upfront allogeneic transplantation versus JAK inhibitor therapy for patients with myelofibrosis: a North American collaborative studyDawn Maze, Murat O Arcasoy, Ryan Henrie, et al.
Bone Marrow Transplantation|April 2, 2020
Curability and transferability of atopy with allogeneic hematopoietic cell transplantationSarah Whiteside, Alex Chin, Gaurav Tripathi, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 13, 2015
Low Counts of B Cells, Natural Killer Cells, Monocytes, Dendritic Cells, Basophils, and Eosinophils are Associated with Postengraftment Infections after Allogeneic Hematopoietic Cell TransplantationPeter J Podgorny, Laura M Pratt, Yiping Liu, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 2, 2011
Development and validation of a test dose strategy for once-daily i.v. busulfan: importance of fixed infusion rate dosingS Bill Kangarloo, Farrukh Naveed, Ella S M Ng, et al.
Pageof 10

Showing results (61-70 of 92) with videos related to

Sort By:
Pageof 10
Plos One|December 16, 2024
The challenge of preventing extinctions: Lessons from managing threatened land snails on Norfolk IslandIsabel T Hyman, Monique Van Sluys, Junn Kitt Foon, et al.
Current Oncology (Toronto, Ont.)|December 22, 2022
Abstracts of the Cell Therapy Transplant Canada 2022 Annual ConferenceStephanie A Maier, Tobias Berg, Susan Berrigan, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 24, 2018
Choosing Wisely BMT: American Society for Blood and Marrow Transplantation and Canadian Blood and Marrow Transplant Group's List of 5 Tests and Treatments to Question in Blood and Marrow TransplantationSita Bhella, Navneet S Majhail, Jeffrey Betcher, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 11, 2014
Immune cell subset counts associated with graft-versus-host diseasePeter J Podgorny, Yiping Liu, Poonam Dharmani-Khan, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 23, 2013
Establishing a target exposure for once-daily intravenous busulfan given with fludarabine and thymoglobulin before allogeneic transplantationJames A Russell, Shahbal B Kangarloo, Tyler Williamson, et al.
Bone Marrow Transplantation|November 8, 2023
Upfront allogeneic transplantation versus JAK inhibitor therapy for patients with myelofibrosis: a North American collaborative studyDawn Maze, Murat O Arcasoy, Ryan Henrie, et al.
Bone Marrow Transplantation|January 26, 2024
Correction: Upfront allogeneic transplantation versus JAK inhibitor therapy for patients with myelofibrosis: a North American collaborative studyDawn Maze, Murat O Arcasoy, Ryan Henrie, et al.
Bone Marrow Transplantation|April 2, 2020
Curability and transferability of atopy with allogeneic hematopoietic cell transplantationSarah Whiteside, Alex Chin, Gaurav Tripathi, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 13, 2015
Low Counts of B Cells, Natural Killer Cells, Monocytes, Dendritic Cells, Basophils, and Eosinophils are Associated with Postengraftment Infections after Allogeneic Hematopoietic Cell TransplantationPeter J Podgorny, Laura M Pratt, Yiping Liu, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 2, 2011
Development and validation of a test dose strategy for once-daily i.v. busulfan: importance of fixed infusion rate dosingS Bill Kangarloo, Farrukh Naveed, Ella S M Ng, et al.
Pageof 10